EcoR1 Capital, LLC 13D and 13G filings for ORIC Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-05 6:36 pm Purchase | 2025-07-29 | 13G | ORIC PHARMACEUTICALS INC ORIC | EcoR1 Capital, LLC | 6,728,116 6.900% | 3,310,048 (+96.84%) | Filing |
| 2024-11-14 5:54 pm Sale | 2024-09-30 | 13G | ORIC PHARMACEUTICALS INC ORIC | EcoR1 Capital, LLC | 3,418,068 4.900% | -2,857,142 (-45.53%) | Filing |
| 2024-02-14 6:19 pm Purchase | 2023-12-31 | 13G | ORIC PHARMACEUTICALS INC ORIC | EcoR1 Capital, LLC | 6,275,210 8.900% | 2,857,142 (+83.59%) | Filing |
| 2023-02-10 1:56 pm Sale | 2022-12-31 | 13G | ORIC PHARMACEUTICALS INC ORIC | EcoR1 Capital, LLC | 3,418,068 7.600% | -50,876 (-1.47%) | Filing |
| 2022-02-14 3:02 pm Purchase | 2021-12-31 | 13G | ORIC PHARMACEUTICALS INC ORIC | EcoR1 Capital, LLC | 3,468,944 8.800% | 376,726 (+12.18%) | Filing |